Labshake search
Citations for Agilent :
1 - 13 of 13 citations for PD L1 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... PD-L1 (clone 22C3; Dako; 1:150). Briefly ...
-
bioRxiv - Cancer Biology 2023Quote: ... PD-L1 TPS was determined using the Dako PD-L1 IHC 22C3 pharmDx kit (Agilent Technologies, Santa Clara, CA), which is approved by the US Food and Drug Administration.
-
bioRxiv - Cancer Biology 2019Quote: ... CD8 clone SP57 (Ventana Medical Systems) and PD-L1 clone 22C3 (Agilent Technologies). The CD8 assay was performed on the Ventana automated immunostainer BenchMark ULTRA ...
-
bioRxiv - Immunology 2020Quote: ... paraffin-embedded tumor tissue samples were stained for PD-L1 (clone 22C3, Agilent) using the Ventana Benchmark Ultra ...
-
bioRxiv - Cancer Biology 2022Quote: ... and programmed cell death ligand 1 (PD-L1; clone 22C3, pharmDx kit, Agilent, USA) were used ...
-
bioRxiv - Biochemistry 2021Quote: ... for 30 min and visualized using the PD-L1 IHC 22C3 pharmDx (SK006, Dako, Spain). To detect Kim-1 ...
-
bioRxiv - Cancer Biology 2023Quote: ... PD-L1 expression was assessed using the US Food and Drug Administration-approved Dako PD-L1 IHC 22C3 pharmDx kit (Agilent Technologies, Santa Clara, CA) in the samples ...
-
bioRxiv - Immunology 2021Quote: ... and then counterstained with hematoxylin using an automated Dako PD-L1 IHC 22C3 pharmDx platform (Agilent Technologies, Santa Clara, CA). The images were taken using a light microscope (CKX41 Inverted Microscope ...
-
bioRxiv - Pathology 2020Quote: ... 50 slides were stained with PD-L1 IHC 22C3 pharmDx assay according to a standard staining protocol using appropriate automated staining devices (Dako Autostainer Link 48 platform). 65 slides were stained with anti-human PD-L1 rabbit monoclonal antibody (clone SP142 ...
-
bioRxiv - Cancer Biology 2023Quote: ... that were freshly obtained prior to start of pembrolizumab (n=32) using the companion diagnostic assay of pembrolizumab (PD-L1 IHC 22C3 pharmDx, Agilent Technologies, Carpinteria, CA, USA). When no fresh tumor biopsy was available ...
-
bioRxiv - Cancer Biology 2022Quote: ... Slides were then incubated with anti-PD-L2 (CST #82723) diluted 1:25 in EnVision FLEX antibody diluent (Dako) over night at 4º C ...
-
bioRxiv - Physiology 2023Quote: Oxygen consumption rate (OCR) in NIH-3T3-L1 adipocytes treated with exogenous mitochondria was measured using the Seahorse XF24 Extracellular Flux Analyzer (Agilent, Santa Clara, CA, USA) with slight modifications of the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2023Quote: ... The dishes were plasma treated with mesh in place using a chamber (Harrick Plasma, Cleaner PD-32G) applied in a vacuum (Agilent Technologies ...